| Kelli Kidd, MS,CCC-SLP | |
|
2804 Greenhill Blvd Nw, Suite 102, Fort Payne, AL 35968-3066 | |
| (256) 979-1222 | |
| (256) 979-1223 |
| Full Name | Kelli Kidd |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2804 Greenhill Blvd Nw, Fort Payne, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740674316 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3375 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Kidd, MS,CCC-SLP 2804 Greenhill Blvd Nw, Suite 102, Fort Payne, AL 35968-3066 Ph: (256) 979-1222 | Kelli Kidd, MS,CCC-SLP 2804 Greenhill Blvd Nw, Suite 102, Fort Payne, AL 35968-3066 Ph: (256) 979-1222 |
News Archive
In this Kaiser Health News Different Takes feature, The University Of Maryland's Dr. E. Albert Reece and The Heritage Foundation's Stuart Butler discuss how health enterprise zones, a new take on an old economic development idea, might be used to improve the health of the state's minority populations (2/23). Read the commentaries by Reece and Butler.
Thailand has already met most of the development goals agreed at the U.N. Millennium Summit attended by world leaders four years ago.
A panel of experts convened by the RAND Corporation has recommended actions that communities around the United States should take to be better prepared to deal with bioterrorist attacks, pandemic flu outbreak and other large-scale public health emergencies.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
› Verified 3 days ago
Sheila Knox, M.ED.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2804 Greenhill Blvd Nw, Suite 102, Fort Payne, AL 35968 Phone: 256-979-1222 Fax: 256-979-1223 | |
Kathy Dobbs, CCCMSSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 213 38th St Ne, Fort Payne, AL 35967 Phone: 256-844-2992 Fax: 256-844-2994 | |
Amanda Lambert, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2804 Greenhill Blvd Nw, Suite 102, Fort Payne, AL 35968 Phone: 256-979-1222 Fax: 256-979-1223 | |
Mrs. Madge Dunmyer Gower, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6604 Hiawatha Dr Nw, Fort Payne, AL 35967 Phone: 256-845-3072 | |
Katie Malone, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2804 Greenhill Blvd Nw, Suite 102, Fort Payne, AL 35968 Phone: 256-979-1222 Fax: 256-979-1223 | |
Hannah Nicole Shultz, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-997-2460 | |
Mrs. Christie Paschal Wilson, MS CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 200 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-997-2460 |